Hello everyone,
I am launching a (free) biotech due diligence newsletter that focuses on stocks with upcoming PDUFA dates (https://thebiotechreport.substack.com/p/coming-so…).
The reports include analysis of clinical trials, technology, potential market size, probability of FDA approval, competitors, management etc...
I am publishing my first write-up soon (on Akebia Therapeutics $AKBA).
So I was wondering if anyone had any ideas for the format, do I exclusively publish write-ups? Do I publish articles about new technologies?
I am also not completely set on the monetizing strategy (any input welcome!)
I am not from a finance background (biotech consulting), so I am really interested in hearing opinions from people in finance (EQ, IB, HFs etc..)
Thanks!
lifesciences, pure crickets, that's where I come in. Any of these useful?
More suggestions...
You're welcome.
Subscribed, used to cover AKBA and looking forward to your writeup.
Why not publish ahead of key readouts in addition to PDUFA dates? Interest in your work will be higher when there's more uncertainty around the topic that you're covering. If a compound has stellar phase 3 data then the PDUFA date can be an almost non-event, implied PoS could be nearly 100% heading into it.
Thanks a lot for your feedback! I like the idea a lot
Subscribed. Happy to provide feedback if you're interested.
Sit ipsa fugiat vitae tempore dolore est natus. Soluta accusantium ut sed. Omnis est culpa dolor modi iure suscipit expedita ex. Magnam eligendi distinctio ipsam dolores consequuntur vel.
Ullam natus et expedita hic quidem quasi. Tempora dolor sed ut quisquam ullam. Dolores saepe quod qui fugit sint sed. Sed vero corporis modi quisquam voluptatem fugit et et. Sapiente enim temporibus numquam sit magnam magni.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...